Pharmaceutical Misrepresentation
Pharmaceutical Misrepresentation is a form of deceptive trade practice in which a pharmaceutical entity intentionally or negligently communicates false or misleading information about a drug’s safety, efficacy, or intended use, thereby distinguishing it from other regulatory violations by its reliance on falsity or omission in commercial speech to influence prescribers, patients, or regulatory bodies.
17
Publications
2.2K
Citations
24
Authors
8
Institutions
Publications per year
2017–2026
1
17
On the Take: How Medicine’s Complicity with Big Business Can Endanger your Health
Valéria C. Rolla, Marília Santini de Oliveira · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 2008 · 204 citations · Full text
Health Professions, Internal Medicine, Clinical Medicine +15
Drug Companies & Doctors: A Story of Corruption
Alison Bass, Melody Petersen, Sarah Crichton et al. · 2009 · 132 citations
1–5 of 17
24
1 publications · 132 citations
1
h-index
1
h-index
1 publications · 143 citations
1
h-index
1
h-index
1
h-index
1–5 of 24
8
Harvard University
Cambridge, United States
1 h-index
1 publications
40 citations
Bentley University
Waltham, United States
1 h-index
1 publications
40 citations
California State University, Northridge
Northridge, United States
1 h-index
1 publications
48 citations

York University
Toronto, Canada
1 h-index
1 publications
40 citations
Transnational Press London
Sale, United Kingdom
1 h-index
1 publications
47 citations
Rowan University
Glassboro, United States
1 h-index
1 publications
40 citations

Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
1 h-index
2 publications
408 citations
The University of Texas Southwestern Medical Center
Dallas, United States
1 h-index
1 publications
27 citations
1–8 of 8
2 publications · 169 citations
2
h-index
CRO · 2 publications · 913 citations
2
h-index
1 publications · 27 citations
1
h-index
MFM · 1 publications · 143 citations
1
h-index
JLME · 1 publications · 40 citations
1
h-index
1–5